Hormonal and reproductive factors and pancreatic cancer risk: A prospective cohort study

Pancreas

Volumn 30, Issue 4, 2005, Pages 369-374

  Navarro Silvera, Stephanie A ^a   Miller, Anthony B ^b   Rohan, Thomas E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cohort; Hormones; Pancreatic neoplasms; Reproductive factors

Indexed keywords

ESTROGEN RECEPTOR; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CANADA; CANCER RISK; COHORT ANALYSIS; DATA ANALYSIS; FEMALE; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; PANCREAS CANCER; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCTION; RISK FACTOR; SURVIVAL;

ADULT; CANADA; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; GONADAL STEROID HORMONES; HUMANS; INCIDENCE; MENARCHE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREATIC NEOPLASMS; POSTMENOPAUSE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 17844373854     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000160301.59319.ba     Document Type: Article

References (36)

1. Ekbom A, Hunter D. Pancreatic cancer. In: Adami H, Hunter D, Trichopoulos D, eds. Textbook of Cancer Epidemiology. Oxford: Oxford University Press; 2002:233-247.
2. Fuchs CS, Colditz GA, Stampfer MJ, et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med. 1996;156:2255-2260.
3. Ullberg S, Bengtsson G. Autoradiographic studies with natural estrogens. Acta Endocrinol. 1963;43:75-86.
4. Adami H, Persson I, Hoover R, et al. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer. 1989;44:833-839.
5. Bueno de Mesquita HB, Maisonneuve P, Moerman C, et al. Anthropometric and reproductive variables and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int J Cancer. 1992;52:24-29.
6. Fernandez E, La Vecchia C, Sloan M. Menstrual and reproductive factors and pancreatic cancer risk in women. Int J Cancer. 1995;62:11-14.
7. Hanley AJG, Johnson KC, Villenueve PJ, et al. Physical activity, anthropometric factors and risk of pancreatic cancer: results from the Canadian Enhanced Cancer Surveillance System. Int J Cancer. 2001;94: 140-147.
8. Ji BT, Hatch MC, Chow WH, et al. Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China. Int J Cancer. 1996;66:432-437.
9. Karlson BM, Wuu J, Hsieh C, et al. Parity and the risk of pancreatic cancer: a nested case-control study. Int J Cancer. 1998;77:224-227.
10. Kreiger N, Lacroix J, Sloan M. Hormonal factors and pancreatic cancer in women. Ann Epidemiol. 2001;11:563-567.
11. Skinner HG, Michaud DS, Colditz GA, et al. Parity, reproductive factors, and the risk of pancreatic cancer in women. Cancer Epidemiol Biomark Prev. 2003;12:433-438.
12. Persson I, Yuen J, Bergkvist L, et al. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy-long-term follow-up of a Swedish cohort. Int J Cancer. 1996;67:327-332.
13. Kvale G, Heuch I, Nilssen S. Parity in relation to mortality and cancer incidence: a prospective study of Norwegian women. Int J Epidemiol. 1994;23:691-699.
14. Terry PD, Miller AB, Jones JG, et al. Cigarette smoking and the risk of invasive epithelial ovarian cancer in a prospective cohort study. Eur J Cancer. 2003;39:1157-1164.
15. Miller AB, Baines CJ, To T, et al. Canadian National Breast Screening Study. I. Breast cancer detection and death rates among women aged 40-49 years. II. Breast cancer detection and death rates among women aged 50-59 years. CMAJ. 1992;147:1459-1488.
16. Rohan TE, Hartwick W, Miller AB, et al. Immunohistochemical detection of c-erbB-2 and p-53 in benign breast disease and breast cancer risk. J Natl Cancer Inst. 1998;90:1262-1269.
17. Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia: Lippincott-Raven; 1998.
18. Andren-Sandberg A, Hoem D, Backman PL. Other risk factors for pancreatic cancer: hormonal aspects. Ann Oncol. 1999;10:S131-S135.
19. Robles-Diaz G, Duarte-Rojo A. Pancreas: a sex steroid-dependent tissue. IMA J. 2001;3:364-368.
20. Sumi C, Longnecker DS, Roebuck BD, et al. Inhibitory effects of estrogen and castration on the early stage of pancreatic carcinogenesis in Fischer rats treated with azaserine. Cancer Res. 1989;49:2332-2336.
21. Meijers M, Woutersen RA, van Garderen-Hoetmer A, et al. Effects of castration, alone and in combination with aminoglutethimide, on growth of (pre)neoplastic lesions in exocrine pancreas of rats and hamsters. Carcinogenesis. 1991;21:1707-1713.
22. Nakamura S, Yamada T, Hashimoto T, et al. Estradiol alleviates acinar cell apoptosis and chronic pancreatitis in male Wistar Bonn/Kobori rats. Pancreas. 2003;26:e59-e66.
23. Kalapothaki V, Tzonou A, Hsieh CC, et al. Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma. Cancer Causes Control. 1993;4:375-382.
24. La Vecchia C, Negri E, Franceschi S, et al. Long-term impact of reproductive factors on cancer risk. Int J Cancer. 1993;53:251-219.
25. Palmer J, Wise LA, Horton NJ, et al. Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst. 2003;95: 478-483.
26. Liu Q, Wuu J, Lambe M, et al. Transient increase in breast cancer after giving birth: postpartum period with the highest risk. Cancer Causes Control. 2002;13:299-305.
27. Michaud DS. Epidemiology of pancreatic cancer. Minerva Chir. 2004;59: 99-11.
28. Dorman JS, Burke JP, McCarthy BJ, et al. Temporal trends in spontaneous abortion association with type 1 diabetes. Diabetes Res Clin Pract. 1999; 43:41-47.
29. Dorman JS, Steenkiste AR, Foley TP, et al. Menopause in type 1 diabetic women. Is it premature? Diabetes. 2001;50:1857-1862.
30. Kjaer K, Hagen C, Sando S, et al. Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to control subjects. J Clin Endocrinol Metab. 1992;75:524-529.
31. Palin SL, Kumar S, Sturdee DW, et al. HRT in women with diabetes-review of the effects on glucose and lipid metabolism. Diabetes Res Clin Pract. 2001;54:67-77.
32. Strotymeyer ES, Steenkist AR, Foley TP, et al. Menstrual cycle differences between women with type 1 diabetes and women without diabetes. Diabetes Care. 2003;26:1016-1021.
33. Yeshaya A, Orvieto R, Dicker D, et al. Menstrual characteristics of women suffering from insulin-dependent diabetes mellitus. Int J Fertil. 1995;40: 269-273.
34. Palin SL, Kumar S, Sturdee DW, et al. HRT in women with diabetes - review of the effects on glucose and lipid metabolism. Diabetes Res Clin Pract. 2001;54:67-77.
35. Lopez-Lopez R, Huerta R, Malacara JM. Age at menopause in women with type 2 diabetes mellitus. Menopause. 1999;6:174-178.
36. National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003. (U.S. Department of Health and Human Services, National Institutes of Health, 2003. Rev. ed.) Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health; 2004.